pregnancy

Lamotrigine and Pregnancy: Meta-Analysis Shows No Increase in Risk for Malformations

  Maintenance treatment with a mood stabilizer during pregnancy can significantly reduce the risk of relapse in women with bipolar disorder; however, many of the mood stabilizers commonly used in this setting, including lithium and [...]

By |2025-06-26T09:07:02-04:00May 8th, 2017|Anti-Epileptic Drugs, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Lamotrigine and Pregnancy: Meta-Analysis Shows No Increase in Risk for Malformations

In Brief: Beta Blockers and Pregnancy, No Observed Increase in Risk of Malformations

Beta blockers are the most commonly used class of medication for treating cardiac conditions in pregnant women.  They are also effective for the treatment of anxiety symptoms, most commonly performance anxiety. According to a report [...]

By |2017-05-04T15:29:30-04:00May 4th, 2017|Anti-Anxiety Medications, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on In Brief: Beta Blockers and Pregnancy, No Observed Increase in Risk of Malformations

More Data on Pregabalin (Lyrica) and Pregnancy

Pregabalin (marketed in the US as Lyrica) is approved by the US Food and Drug Administration for the treatment of epilepsy, fibromyalgia, and neuropathic pain.  It is also used off-label to treat psychiatric disorders, most [...]

By |2017-05-02T15:49:43-04:00May 2nd, 2017|Anti-Anxiety Medications, Anti-Epileptic Drugs, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on More Data on Pregabalin (Lyrica) and Pregnancy

Is BDNF a Biomarker for Depression During Pregnancy and the Postpartum Period?

Brain-derived neurotrophic factor (BDNF) is a growth factor which acts on neurons in both the central and peripheral nervous systems, promoting the survival of neurons and promoting the growth and differentiation of new neurons and [...]

By |2017-01-19T13:10:58-04:00January 19th, 2017|Depressive Disorders, Postpartum Psychiatric Disorders, Psychiatric Disorders During Pregnancy|Comments Off on Is BDNF a Biomarker for Depression During Pregnancy and the Postpartum Period?

USPSTF Emphasizes Periconceptual Use of Folic Acid to Prevent Birth Defects

Neural tube defects are among the most common major congenital anomalies in the United States and are associated with significant disability and death.  The risk of neural tube defects can be prevented with daily folic [...]

By |2017-01-13T10:34:56-04:00January 10th, 2017|Psychiatric Disorders During Pregnancy, Risk of Malformations|Comments Off on USPSTF Emphasizes Periconceptual Use of Folic Acid to Prevent Birth Defects

The 50-year Quest for Better Pregnancy Data

The following post was first published in OB/GYN News. Please see our OB/GYN News archives here. Publish date: November 1, 2016 By: Gerald G. Briggs, BPharm, FCCP, Christina Chambers, PhD, MPH, Lee S. Cohen, MD, & Gideon Koren, MD Editor’s note: As [...]

By |2020-11-21T07:53:47-04:00January 3rd, 2017|Pregnancy & Medications|Comments Off on The 50-year Quest for Better Pregnancy Data

MCPAP for Moms: Exploring New Strategies for Providing Care to Women with Perinatal Depression

We are clearly making big strides in terms of increasing public awareness of perinatal mood and anxiety disorders, but we still have a long way to go when it comes to providing access to mental [...]

By |2016-12-06T22:20:45-04:00December 7th, 2016|Depressive Disorders, Psychiatric Disorders During Pregnancy|Comments Off on MCPAP for Moms: Exploring New Strategies for Providing Care to Women with Perinatal Depression

Prenatal Exposure to Levetiracetam and Topiramate: No Evidence of Cognitive Deficits

Many of the newer antiepileptic drugs (AEDs) have uses beyond the treatment of epilepsy.  Topiramate (marketed as a Topamax), in addition to its use for the treatment of epilepsy, is now being prescribed to reproductive [...]

By |2016-10-03T11:24:32-04:00October 3rd, 2016|Pregnancy & Medications|Comments Off on Prenatal Exposure to Levetiracetam and Topiramate: No Evidence of Cognitive Deficits
Go to Top